Novartis (NVS) Free Cash Flow (2006 - 2026)
Novartis (NVS) free cash flow from Mar 31, 2006 to Mar 31, 2026. The TTM Novartis (NVS) free cash flow is $16B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Novartis (NVS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +10.18% |
| 3 Years TTM | +6.95% |
| 5 Years TTM | +9.71% |
| 10 Years TTM | +7.56% |
| All Time TTM | +5.20% |
Annual Free Cash Flow change of Novartis (NVS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $2.87B | -83.78% |
| 2025 | $18B | +28.11% |
| 2024 | $14B | +17.94% |
| 2023 | $12B | +1.21% |
| 2022 | $12B | -4.42% |
| 2021 | $12B | +9.35% |
| 2020 | $11B | -2.67% |
| 2019 | $11B | +4.13% |
| 2018 | $11B | +10.55% |
| 2017 | $9.88B | +14.88% |
| 2016 | $8.60B | +6.84% |
| 2015 | $8.05B | -21.07% |
| 2014 | $10B | +8.46% |
| 2013 | $9.40B | -13.68% |
| 2012 | $11B | -8.66% |
| 2011 | $12B | +0.74% |
| 2010 | $12B | +25.13% |
| 2009 | $9.46B | +26.90% |
| 2008 | $7.45B | +22.64% |
| 2007 | $6.08B | -4.87% |
| 2006 | $6.39B | N/A |
Comparison Novartis (NVS) five years free cash flow CAGR with competitors
Novartis (NVS) five years free cash flow CAGR is 9.71%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 21.25% | +118.87% |
| AZN | Astrazeneca plc | 15.68% | +61.49% |
| SNY | Sanofi | 8.08% | -16.74% |
| MRK | Merck & Co Inc | 5.49% | -43.46% |
| GILD | Gilead Sciences Inc | 3.30% | -66.04% |
| ABBV | Abbvie Inc | 2.35% | -75.80% |